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Abstract
Background: Hirschsprung’s disease (HSCR) is a congenital disorder associated with the lack of intramural ganglion cells in
the myenteric and sub-mucosal plexuses along varying segments of the gastrointestinal tract. The RET gene is the major
gene implicated in this gastrointestinal disease. A highly recurrent mutation in RET (RET
R114H) has recently been identified in
,6–7% of the Chinese HSCR patients which, to date, has not been found in Caucasian patients or controls nor in Chinese
controls. Due to the high frequency of RET
R114H in this population, we sought to investigate whether this mutation may be a
founder HSCR mutation in the Chinese population.
Methodology and Principal Findings: To test whether all RET
R114 were originated from a single mutational event, we
predicted the approximate age of RET
R114H by applying a Bayesian method to RET SNPs genotyped in 430 Chinese HSCR
patients (of whom 25 individuals had the mutation) to be between 4–23 generations old depending on growth rate. We
reasoned that if RET
R114H was a founder mutation then those with the mutation would share a haplotype on which the
mutation resides. Including SNPs spanning 509.31 kb across RET from a recently obtained 500 K genome-wide dataset for a
subset of 181 patients (14 RET
R114H patients), we applied haplotype estimation methods to determine whether there were
any segments shared between patients with RET
R114H that are not present in those without the mutation or controls.
Analysis yielded a 250.2 kb (51 SNP) shared segment over the RET gene (and downstream) in only those patients with the
mutation with no similar segments found among other patients.
Conclusions: This suggests that RET
R114H is a founder mutation for HSCR in the Chinese population.
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Introduction
Hischsprung’s disease (HSCR) is a congenital disorder associated
with the lack of intramural ganglion cells in the myenteric and sub-
mucosal plexuses along varying segments [short-segment aganglio-
nosis (S-HSCR), long-segment aganglionosis (L-HSCR) and total
colonic aganglionosis (TCA)] of the gastrointestinal tract. There is
significant racial variation in the incidence of the diseaseand it is most
often found among Asians(28 per 100,000 live births) [1,2]. The male
to female ratio (M:F) is ,4:1 among S-HSCR patients and ,1:1
among L-HSCR patients. The recurrence risks to siblings vary from
1.5 to 33% depending on gender and length of the aganglionic
segment in the proband and the gender of the sibling. In general,
HSCR presentsmostlysporadically,although it canbe familial with a
complex pattern of inheritance, including low, sex-dependent
penetrance and phenotypic variability. HSCR has also a complex
genetic aetiology; many studies have indicated receptor tyrosine
kinase (RET) as the major susceptibility gene for HSCR [3,4].
Mutations in the coding regions of RET account for over 50% of the
familial cases, and between 7%–35% of the sporadic cases. RET
mutations are not fully penetrant indicating that the disease may
result from the combined effect of RET and other interacting disease
susceptibility alleles.
Some disorders are characterised by a mutation(s) that can be
traced back to a founder and whose existence can be inferred from
the unique chromosomal background on which the mutation
occurred. Some founder mutations may be a major cause of the
disorder, because they lead to a specific phenotype–the disease
occurs only if that mutation is present. Alternatively, there is no
specific correlation with phenotype but the reproductive history
within a given population led to a relatively high frequency for the
mutation and, thus, to its becoming a major cause of a disease.
PLoS ONE | www.plosone.org 1 June 2010 | Volume 5 | Issue 6 | e10918Genetic mapping, family based association studies, comparative
sequence analysis and functional studies cumulatively provided
evidence for a common polymorphism (rs2435357: CRT) in
intron 1 of RET that is the strongest contributor to HSCR risk
[5,6]. This SNP is common among different populations including
Asians. Additionally it has been demonstrated that HSCR
European and Chinese patients share the same background
haplotype containing this high risk SNP although the frequency of
the disease haplotype is higher in Chinese than in Europeans [7,8].
Thus far, over 200 non recurrent RET coding sequence (CDS)
mutations have been identified in HSCR patients. In a 2004 study
[9], a highly recurrent (6–7% of the patients) heterozygous missense
mutation was identified in the extracellular domain (exon 3) of the
RET protein (RET
R114H mutation; c.341G.A according to
NP_066124.1 and NM_020975.4 respectively). The frequency of
RET
R114H has remained stable after having sequenced 262 additional
Chinese HSCR patients [10]. This mutation was not found in
Chinese controls (N=224) nor has it been found, to date, in
Caucasian HSCR cases or controls. The high recurrence of
RET
R114H in Chinese HSCR patients lead us to investigate whether
its frequency is due to a possible mutational hot spot (i.e. arisen
independently) or, perhaps, a possible founder mutation for a sub-
population of HSCR patients whose significance is not yet known.
Haplotype studies could help to determine if a specific mutation
appears to occur on a common genetic background suggesting it
has been inherited from a common ancestor, or if the shared
mutation appears to have arisen independently multiple times. In
the current study, we use haplotype methods in a case-control
Chinese HSCR sample to determine the relative importance of the
RET
R114H mutation in the evolution of HSCR in Asia.
Materials and Methods
Subjects and Measures
Patients and their families were referred by family members or
their physicians. Their participation as well as the participation of
healthy controls was conditional upon informed written consent
under the ethical guidance of the Institutional Review Board of
The University of Hong Kong together with the Hospital
Authority (IRB: UW06-349 T/1374). A total of 430 Chinese
HSCR patients and 632 Chinese controls were included in the
study. Diagnosis of HSCR was based on histologic examination of
either biopsy or surgical resection material for absence of enteric
plexuses. Blood samples were drawn from all patients after
obtaining informed written consent but where participants were
newborns or under the age of seven, parental consent was
obtained instead.
RET SNP genotyping and sequencing. All participants (430
patients and 224 controls) were genotyped for 21 RET SNPs across a
,60 kb region of RET as well as sequenced for the 21 RET exons.
See supplementary table, Table S1, for a further description of these
SNPs. DNA for genotyping was extracted from peripheral blood
using a Qiagen kit. Genotyping was carried out by primer extension
(MassEXTEND), and MALDI-TOF (Matrix Assisted Laser
Desorption Ionization-Time Of Flight) mass spectrometry as the
read-out system on a Sequenom platform (Sequenom MassARRAY
system, Sequenom, San Diego CA), according to the manufacturer’s
instructions and as previously described in Garcia-Barcelo et al. [11].
Sequencing of RET exons was performed as previously described.
Among the 430 HSCR patients, the RET
R114H mutation [9] was
identified in 25 (,6%) patients.
All 21 SNPs tested had a call rate of over 95% and were in
Hardy-Weinberg equilibrium after correcting for multiple testing.
All SNPs, except rs302678, were polymorphic.
500 K Genome-wide Scan. Forty six additional SNP
genotypes encompassing the RET gene 6250 kb were obtained
through a genome-wide association study (GWAS) conducted on
181 HSCR patients selected from the original sample of 430
HSCR patients. For this GWAS, controls consisted of 306
individuals (106 males, 200 females) of southern Chinese origin
participating in an ongoing GWA study aimed at the discovery of
genetic factors for the quantitative trait of disk degeneration (DD)
(see Garcia-Barcelo et al. [12]) for further information) as well as a
derived synthetic control set formed by combining the non-
transmitted alleles from some of the parents of HSCR cases, or
‘‘pseudo-controls’’ (N=57), and Affymetrix generated genotypes for
the Chinese Han population (N=45) retrieved from the
International HapMap Project. This provided a total control
sample of 408 individuals for this GWA study.
Statistical Data Analyses
Haplotype Analysis. Haplotypes were estimated using the
statistical software package PHASE version 2.1 [http://www.stat.
washington.edu/stephens/; [13,14,15]], a program based on a
Bayesian statistical method using coalescent-based models that
infers phases at loci from unphased genotype data for a sample of
unrelated individuals [13], though extensions to related individuals
are possible [16]. The algorithm uses a flexible model for the decay of
linkage disequilibrium with distance and explicitly incorporates an
assumption about recombination rate variation. PHASE uses Gibbs
sampling, a Markov-Chain Monte Carlo algorithm [17] for the
estimation of the posterior distribution. Hence, the individual
haplotype can be estimated from the posterior distribution by
choosing the most likelyhaplotype reconstruction for each individual.
Using the extension for unrelated individuals, we used the
default settings for recombination rate variation [18] to infer the
haplotypes from the genotype data of the 21 SNPs and the
RET
R114H mutation (used as a SNP in the analysis) for 430 patients
(25 with RET
R114H mutation) and again for the additional 46 SNPs
added to the sample (N=68 SNPs) for a subsample of 181 cases
(14 of whom have the RET
R114H mutation). Estimates of the
sample haplotype frequencies together with their standard
deviation, a list of the most likely pairs of haplotypes for each
individual together with their probability, and the estimates of
recombination parameters in the region, were calculated using the
same software under the assumption of a stepwise mutation
mechanism for multiallelic loci.
Age of Mutation Analysis. DMLE+ version 2.2 developed
by Reeve and Rannala (2002) [19] (http://dmle.org/) was used to
estimate the age of the RET
R114H mutation. This program was
designed for high-resolution mapping of a disease mutation and
estimation of its age. The method is based on the observed linkage
disequilibrium between a disease mutation and linked markers in
DNA samples of unrelated normal individuals and affected
patients. The program uses the Markov Chain Monte Carlo
algorithm to allow Bayesian estimation of the mutation age based
on the following parameters: the observed genotypes (or
haplotypes) in samples of unrelated normal or affected
chromosomes, map distances between markers and the position
of the mutation relative to the markers and the estimated
population growth rate. Simulation analyses have shown that
good results are obtainable even with a fair degree of genetic
heterogeneity and phenocopy, and incomplete penetrance [20].
In addition to the genotypic data, marker (or SNP) location,
population growth rate, and an estimate for the proportion of
disease bearing chromosomes being analysed are used by the
software. We used recommended burn-in and sampling intervals
and a variety of modeling assumptions and parameter ranges. In
RET Founder Mutation
PLoS ONE | www.plosone.org 2 June 2010 | Volume 5 | Issue 6 | e10918this study the parameters used were the haplotypes generated from
21 SNPs in unrelated normal and affected individuals (as this
information was available for the most number of cases and
controls), the chromosome map distances between markers and
disease mutations, and 0.02834% mean carrier frequency of
RET
R114H mutation (estimated from number of disease chromo-
somes in sample). For the population growth rate, we took data
from the Hong Kong Census and Statistics Department (http://
www.censtatd.gov.hk/home/index.jsp), which records population
figures back to 1961. The department records show that, on
average, the population growth rate has decreased with time; so to
account for this, we used an average growth rate across the whole
time period (1.7%) as well as using two extreme growth rates on
record–the highest growth rate recorded was 5.4% in 1962 and
the lowest growth rate was 0.3% in 2001. To compare results, we
also performed the estimation using the 2007 growth rate
(0.606%).
One disadvantage with the program is that it does not allow
information about the mutation genotype (in the disease chromo-
somes) and the location of the mutation to be used simultaneously.
Therefore, the program was run once with mutation location
specified and with no genotype information included and once
with genotype information and mutation location freed. Both
returned similar results.
Results and Discussion
Preliminary Haplotype Analysis
To determine whether all occurrences of RET
R114H mutation
descended from a single ancestral mutation event or arisen
independently, we first constructed haplotypes with 21 RET region
SNP genotypes from 224 controls and 430 HSCR patients of
whom 25 were RET
R114H mutation carriers (see Figure 1).
Haplotype reconstruction, carried out using the statistical
software PHASE v2.1.1, suggested that 61 different haplotypes
exist in the current sample. The software also revealed that every
patient harbouring RET
R114H was predicted with a probability
over 70% to have a common mutation haplotype (T-G-A-C-A-A-
A-T-A-G-A-M-C-G-G-G-C-G-G-C-C-C) which comprises the
HSCR-associated allele T of the intron 1 SNP rs2435357 [5]
[M represents the allele change from the wild type c.341G.A for
RET
R114H; T represents the high risk SNP (rs2435357) in intron 1
of RET] (see Table 1). Furthermore, 293 out of the rest of the 406
non-carrier cases (72.17%) were predicted to carry the same
haplotype without the mutation (i.e. T-G-A-C-A-A-A-T-A-G-A-
G-C-G-G-G-C-G-G-C-C-C). Overall, this haplotype accounted
for the largest proportion in the sample. This result was not
surprising given that early results predicted that HSCR patients
are predominantly represented by the same haplotype [8].
However, we reasoned that if this mutation had a single ancestral
origin, carriers would have more chromosomal segments in
common than non-carrier patients.
Age of Mutation
Using the above set of individuals and data, we estimated the
‘‘age’’ of RET
R114H assuming that it has originated from a
common ancestor. The decay of linkage disequilibrium (LD) due
to recombination can be used to date the age of the mutation or
that of its introduction into the analysed population on a particular
haplotype. We used the DMLE+2.2 software to estimate the age of
the mutation using haplotype data from affected patients and
unaffected controls. Figure 2 shows the posterior probability
densities of the mutation age for RET
R114H for the four different
population growth rates.
For the first analysis, which used the most up-to-date growth
rate estimated, the mutation density depicted a peak at ,11–12
generations for RET
R114H. Assuming 20–30 years for a generation,
the age of the RET
R114H mutation was estimated to be between
220–340 years old. The second analysis, which used an average
growth rate, gave an age estimate of 80–120 years (,4
generations). The third analysis used the slowest growth rate on
record and gave an age estimate of 440–690 years (,22–23
generations). The last analysis, which used the fastest growth rate
on record, gave an age estimate of ,36–54 years (,1.8
generations).
Figure 1. Schematic diagram (not to scale) showing the location of SNPs used in the analysis across the RET gene. The exons and
promoter are represented by rectangles (a darker grey is used for those in which a SNP is located). See Table S1 for the name of each SNP represented
in this figure.
doi:10.1371/journal.pone.0010918.g001
RET Founder Mutation
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PLoS ONE | www.plosone.org 4 June 2010 | Volume 5 | Issue 6 | e10918The analysis of the extent of decay of LD between the mutation
and the adjacent SNPs suggests that the founder effect may easily
explain the high frequency of the mutation in the Chinese.
However, although RET
R114H is on the haplotype background
shared by Caucasians and Chinese [5,8], had the mutation
occurred before the European-Asian split, its frequency in our
population would be much higher than that currently observed.
Thus either the mutation is in fact a founder mutation for a sub-
population of Chinese HSCR or more than one carrier has
introduced the mutation into the Chinese population given its
relatively young age.
Extended Haplotype Sharing
We reasoned that if RET
R114H had a single ancestor origin,
carriers would have more chromosomal segments in common than
non-carrier patients. In order to support our hypothesis, we made
use of a subset of samples that had previously been genotyped for a
GWAS (181 patients of whom 14 carry the RET
R114H hetero-
zygous mutation) [12]. Before performing haplotype analysis on
this subsample, we set about to determine whether there were any
groups of individuals (in particular those with the RET
R114H
mutation) that are more related to each other than to other cases
and/or controls. Multidimensional scaling (MDS) in PLINK
version 1.03 [21] was used, which is a set of related statistical
techniques often used to visualize for patterns of subgroupings in
data. There was no clustering of RET
R114H individuals indicating
that no specific similarities were shared more/less between these
individuals at the whole genome level (results not shown).
To be able to include as much information as possible to
increase power for haplotype estimation, we isolated and merged
46 SNPs located on or within the region of 250 kb of RET from
the 500 K genome-wide dataset; therefore PHASE was conducted
on a total sample of 68 SNPs (including the RET
R114H mutation)
across a 509.31 kb region across RET in a total of 181 patients (14
RET
R114H mutation) that were included in both the original
dataset and 500 K genome-wide dataset. Descriptive statistics of
these RET SNPs are shown in the supplementary table, Table S1.
Figure 1 shows a Schematic diagram of the combined RET SNPs
while Table 1 shows haplotype frequencies estimated by the
PHASE program.
PHASE analysis performed on the 68 SNP sample yielded a
250.2 kb (51 SNPs) shared segment over the RET gene (and
downstream) in only RET
R114H patients with no similar segments
found among non-mutant carriers (see Table 1). This demon-
strates that HSCR patients with the RET
R114H mutation have a
common ancestor. The fact that the haplotype of the RET
R114H
patients is longer than that of the other non-mutant patients is in
line with the ‘‘young’’ age of the mutation and lower recombina-
tion across this haplotype. However, the length of the segment
shared between mutant carriers suggest that the mutation may be
older than what has been predicted. In previous studies, it has
been suggested that there are possible recombination events
between intron 5 and intron 8 of the RET gene causing a risk
haplotype frequency difference between Caucasians and Chinese
originating in two ‘‘risk haplotypes’’. It has also been suggested
that the reason for these differences between populations is that
the true RET disease susceptibility allele remains to be identified.
Therefore, the RET
R114H mutation may be a recent (say, a few
centuries) random event that may or may not be in LD with the
true RET causal variant given its relatively young age and its
location on the ‘risky’ haplotype. This suggestion is not unlikely
given the high LD along RET [8,22] and the rarity of the
mutation.
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RET Founder Mutation
PLoS ONE | www.plosone.org 5 June 2010 | Volume 5 | Issue 6 | e10918In conclusion, this study shows that the RET
R114H mutation is
likely a founder mutation in a subset of Chinese HSCR patients.
We could not find any correlation between the mutation and the
severity of the phenotype or gender (two major risk factors) which
is somehow expected given the genetic complexity of the
condition. Yet, the fact that RET
R114H has never been found in
controls and given its high frequency in the Chinese population, it
is tempting to speculate that indeed RET
R114H increases the risk to
disease. Therefore, functional studies to uncover the effect of
RET
R114H on the gene or protein function are warranted.
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